NovartisPharmaceutical Companies

ATIVESITE | Staying one step ahead of the malaria parasite



Interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases (NITD) about the threat of drug resistance and why we need to stay one step ahead of the parasite to reach malaria elimination. Thierry Diagana has dedicated his career to unravelling the complexities of the malaria parasite, which he describes as an “incredibly smart enemy that has shown an uncanny way of defeating everything we’ve thrown at it.”

Learn more: https://bit.ly/3Jq3GVG

©2022 Novartis AG

Source Novartis YouTube

1111

ativesite

Health First, Well-Being Always!